Rare Disease Innovation and Partnering Summit

Boston, Jun 13-14, 2019

Venue：Boston Marriott Long Wharf, Boston, MA

Partnering & Investment Panel - Investing Today in Tomorrow’s Life-Transforming Treatments

During the session, Mike Zhao, Vice President Healthcare at MSQ Ventures discussed and shared insights in ways that investors approach valuation in rare diseases, how and what drives concerns around risk for return on investment, options to manage through rapid go/no-go decisions, evaluating models for funding, and explore creative models to lower the risk to develop drugs for rare disease.

MODERATOR: Michael Pistone, Director, Innovation Acceleration, Innovation Ventures, Cincinnati Children’s Hospital PANELISTS: Imran Babar, Ph.D., Chief Business Officer, Cydan II Inc. Paul Oppold, Vice President, Investments, Roivant Pharma Shinchiro Fuse, Managing Director, MPM Capital Eric Gomez, Associate Director of Asset Acquisition, BridgeBio